Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.

We recently published a list of 10 Most Promising Small-Cap Stocks According to Hedge Funds. In this article, we are going to ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

Zealand Pharma A/S (ZEAL) said that the U.S. Food and Drug Administration has issued a Complete Response Letter or CRL for Part 1 of ...

Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...

No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism U.S. Food and Drug ...

The most effective treatment for neuropathy varies from person to person. Treatment often depends on the underlying cause of the neuropathy, such as vitamin B12 deficiency or diabetes. While ...

‘Glucagon injectables were found to be a game-changer for preventing #hypoglycemia in diabetics. Say goodbye to low #bloodsugar worries! #diabetes #hypoglycemia’ To improve glucagon stability ...

While insulin treatment in diabetic patients is extremely effective in lowering blood glucose from dangerous highs, the authors continued, episodes of moderate to severe hypoglycemia are common ...

However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which can lead to dizziness, cognitive impairment ...